Medivolve Inc. reported earnings results for the third quarter and nine months ended September 30, 2022. For the third quarter, the company reported sales was CAD 6.54 million compared to CAD 25.27 million a year ago. Net loss was CAD 6.97 million compared to net income of CAD 6.86 million a year ago. Basic loss per share from continuing operations was CAD 0.3 compared to basic earnings per share from continuing operations of CAD 0.3 a year ago. Diluted loss per share from continuing operations was CAD 0.3 compared to diluted earnings per share from continuing operations of CAD 0.3 a year ago.
For the nine months, sales was CAD 32.32 million compared to CAD 40.26 million a year ago. Net loss was CAD 14.38 million compared to CAD 12.01 million a year ago. Basic loss per share from continuing operations was CAD 0.6 compared to CAD 0.75 a year ago.